The annual trend has been a gradual climb.
Revenue rose for four consecutive years, from 2,873.2 billion won in 2022 to 2,912.4 billion won in 2023, 3,104.3 billion won in 2024 and 3,332.4 billion won in 2025, while operating profit moved from 466.7 billion won to 492.4 billion won, 543.6 billion won and 558.3 billion won over the same span.
The operating margin, however, eased from 17.5 percent in 2024 to 16.8 percent in 2025, meaning profit growth did not fully keep pace with top-line expansion.
Net profit attributable to owners fell from 524.6 billion won in 2024 to 382.7 billion won in 2025, largely a base effect from non-recurring gains booked in 2024 — the company stated that in calculating the 2024 payout ratio it excluded non-recurring gains related to the LigaChem Biosciences investment from the 524.0 billion won attributable net profit.
The balance sheet is conservative: at end-2025 total equity was 3,912.2 billion won against total liabilities of 686.5 billion won for a debt-to-equity ratio of 17.5 percent, while operating cash flow declined from 651.6 billion won in 2024 to 537.3 billion won in 2025.
Quarterly, margins stepped up from 777.2 billion won in revenue and 121.5 billion won in operating profit (15.6 percent margin) in the second quarter of 2025 to 828.9 billion won and 137.9 billion won (16.6 percent) in the third and 924.6 billion won and 167.6 billion won (18.1 percent) in the fourth.
The first quarter of 2026 delivered revenue of 930.4 billion won, operating profit of 165.5 billion won (17.8 percent) and attributable net profit of 124.5 billion won, among the strongest quarterly profits on record.
In the second quarter of 2026, however, revenue grew 15.0 percent year on year to 893.6 billion won while operating profit rose only 9.2 percent to 132.6 billion won, pulling the margin down to 14.8 percent, and attributable net profit slipped to 86.2 billion won from the prior quarter.
The company pointed to a tight operating environment, citing higher energy and logistics costs and raw material prices amid a prolonged Middle East conflict.
Summing the most recent four quarters gives revenue of 3,577.5 billion won and operating profit of 603.6 billion won, already running above the full-year 2025 figures, though the widening swing in quarterly margins is equally visible.